Hong Kong stock exchange filings reveal that on August 27, China Universal Asset Management Co., Ltd. reduced its holdings in KEYMED BIO-B (02162) by 48,000 shares.
The shares were sold at an average price of HK$78.4010 each, bringing the total transaction value to approximately HK$3.7632 million.
Following this disposal, the fund manager's latest share count in the company stands at 14.892 million shares, which corresponds to a reduced ownership stake of 4.98%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.